Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging

Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) – protocol of a randomized phase II trial (NOA 10/ARO 2013-1)

(2016) Oliver Oehlke et al.   BMC CANCER

Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation

(2016) J. Khalifa et al.   EUROPEAN RADIOLOGY

Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?

(2016) Jonathan Khalifa et al.   JOURNAL OF NEURO-ONCOLOGY

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas

(2016) Nathalie L. Albert et al.   NEURO-ONCOLOGY

Evaluation of the Lactate-to-N-Acetyl-aspartate Ratio Defined With Magnetic Resonance Spectroscopic Imaging Before Radiation Therapy as a New Predictive Marker of the Site of Relapse in Patients With Glioblastoma Multiforme

(2014) Alexandra Deviers et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Radiotherapy Protocol Deviations and Clinical Outcomes: A Meta-analysis of Cooperative Group Clinical Trials

(2013) N. Ohri et al.   JNCI-Journal of the National Cancer Institute

Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost

(2013) Soléakhéna Ken et al.   Radiation Oncology

QA makes a clinical trial stronger: Evidence-based medicine in radiation therapy

(2012) Damien C. Weber et al.   RADIOTHERAPY AND ONCOLOGY

F-18-FDG-PET Confined Radiotherapy of Locally Advanced NSCLC With Concomitant Chemotherapy: Results of the PET-PLAN Pilot Trial

(2011) Jochen Fleckenstein et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Glioblastoma survival in the United States before and during the temozolomide era

(2011) Derek R. Johnson et al.   JOURNAL OF NEURO-ONCOLOGY

Molecular Imaging–Based Dose Painting: A Novel Paradigm for Radiation Therapy Prescription

(2011) Søren M. Bentzen et al.   SEMINARS IN RADIATION ONCOLOGY

Single blind randomized Phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial

(2011) Irene M Lips et al.   Trials

Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02

(2010) Lester J. Peters et al.   JOURNAL OF CLINICAL ONCOLOGY

Online Quality Control, Hyperfractionated Radiotherapy Alone and Reduced Boost Volume for Standard Risk Medulloblastoma: Long-Term Results of MSFOP 98

(2009) Christian Carrie et al.   JOURNAL OF CLINICAL ONCOLOGY

Proton Magnetic Resonance Spectroscopic Imaging in Newly Diagnosed Glioblastoma: Predictive Value for the Site of Postradiotherapy Relapse in a Prospective Longitudinal Study

(2008) Anne Laprie et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM

(2008) Forrest W. Crawford et al.   JOURNAL OF NEURO-ONCOLOGY

Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy

(2008) Suja Saraswathy et al.   JOURNAL OF NEURO-ONCOLOGY

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

(2008) Dieta Brandsma et al.   LANCET ONCOLOGY